ZIMMER BIOMET HOLDINGS, INC.·4

May 14, 5:00 PM ET

BERNARD BETSY J 4

4 · ZIMMER BIOMET HOLDINGS, INC. · Filed May 14, 2024

Insider Transaction Report

Form 4
Period: 2024-05-10
Transactions
  • Award

    Phantom Stock Units

    2024-05-10+616.72619,501.129 total
    Exercise: $121.61Common Stock (616.726 underlying)
  • Award

    Restricted Stock Units

    2024-05-10+1,068.99121,577.928 total
    Common Stock (1,068.991 underlying)
Footnotes (6)
  • [F1]The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.
  • [F2]The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • [F3]These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
  • [F4]Includes 35.416 phantom stock units accrued on January 31, 2024 and 37.432 phantom stock units accrued on April 30, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • [F5]The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
  • [F6]Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES